awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47140442-0FBB1CFE-6165-4C2B-ADA5-92D7BADC6379
Q47140442-0FBB1CFE-6165-4C2B-ADA5-92D7BADC6379
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47140442-0FBB1CFE-6165-4C2B-ADA5-92D7BADC6379
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases.
P2860
Q47140442-0FBB1CFE-6165-4C2B-ADA5-92D7BADC6379
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47140442-0FBB1CFE-6165-4C2B-ADA5-92D7BADC6379
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9f872113878ccbf3d2e34e50baab714ff4b6e6b6
P2860
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiation.